FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / ...

ABL Advisor Search Results

News Stories (4 Results) - K2 HealthVentures

Acumen Pharmaceuticals, a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (“AβOs”) for the treatment of Alzheimer’s disease (“AD”), entered into a senior secured loan and... Read Story
November 13, 2023, 07:50 AM


Mind Medicine, a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, entered into a senior secured credit facility with K2 HealthVentures, a healthcare-focused specialty finance company.Upon... Read Story
August 14, 2023, 07:59 AM


Aptinyx, a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, entered into a $50 million loan facility and security agreement with K2 HealthVentures (K2HV). The funds... Read Story
September 16, 2021, 07:42 AM


VBI Vaccines announced an agreement to drawdown a $12 million second tranche under its previously announced debt financing facility with K2 HealthVentures (K2HV), a healthcare-focused specialty finance company. Under the terms of the debt financing... Read Story
May 24, 2021, 07:00 AM